148 related articles for article (PubMed ID: 12767359)
1. Frequent use of complementary medicine by prostate cancer patients.
Ponholzer A; Struhal G; Madersbacher S
Eur Urol; 2003 Jun; 43(6):604-8. PubMed ID: 12767359
[TBL] [Abstract][Full Text] [Related]
2. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
[TBL] [Abstract][Full Text] [Related]
3. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
[TBL] [Abstract][Full Text] [Related]
4. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
5. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
[TBL] [Abstract][Full Text] [Related]
6. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study.
Nicolaisen M; Müller S; Patel HR; Hanssen TA
J Clin Nurs; 2014 Dec; 23(23-24):3403-14. PubMed ID: 24890131
[TBL] [Abstract][Full Text] [Related]
8. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.
Egger S; Hughes S; Smith DP; Chambers S; Kahn C; Moxey A; O'Connell DL
PLoS One; 2018; 13(3):e0193686. PubMed ID: 29513724
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
11. Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.
Jang A; Kang DH; Kim DU
J Altern Complement Med; 2017 May; 23(5):362-369. PubMed ID: 28453297
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.
Nam RK; Fleshner N; Rakovitch E; Klotz L; Trachtenberg J; Choo R; Morton G; Danjoux C
J Urol; 1999 May; 161(5):1521-4. PubMed ID: 10210387
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer in the older man.
Ko YJ; Bubley GJ
Oncology (Williston Park); 2001 Sep; 15(9):1113-9, 1123-4; discussion 1124-6, 1131. PubMed ID: 11589062
[TBL] [Abstract][Full Text] [Related]
14. Use of complementary and alternative medicine among men with prostate cancer in a rural setting.
Butler S; Owen-Smith A; DiIorio C; Goodman M; Liff J; Steenland K
J Community Health; 2011 Dec; 36(6):1004-10. PubMed ID: 21499937
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence.
Pietrow PK; Parekh DJ; Smith JA; Shyr Y; Cookson MS
J Urol; 2001 Dec; 166(6):2286-90. PubMed ID: 11696753
[TBL] [Abstract][Full Text] [Related]
16. Use of complementary and alternative medicine by lymphoma survivors in South Korea.
Kim K; Kim SH; Ok ON; Kim IR; Lee S; Kim SH; Kim WS; Ryu MH; Lee MH
Eur J Oncol Nurs; 2018 Apr; 33():91-96. PubMed ID: 29551184
[TBL] [Abstract][Full Text] [Related]
17. Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
McDermott CL; Blough DK; Fedorenko CR; Arora NK; Zeliadt SB; Fairweather ME; Oakley-Girvan I; Van Den Eeden SK; Ramsey SD
Support Care Cancer; 2012 Jan; 20(1):65-73. PubMed ID: 21120540
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.
Ramsey SD; Zeliadt SB; Blough DK; Fedorenko CR; Fairweather ME; McDermott CL; Penson DF; Van Den Eeden SK; Hamilton AS; Arora NK
Urology; 2012 May; 79(5):1034-41. PubMed ID: 22546381
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.
Bahall M
BMC Complement Altern Med; 2017 Jun; 17(1):345. PubMed ID: 28666435
[TBL] [Abstract][Full Text] [Related]
20. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
